Oxford University Hospitals NHS Foundation Trust has formed a partnership which is aiming to support researchers assessing the benefit of standard and new treatment options for cancer patients.

The collaboration between the trust and Arcturis Data Limited, a UK leader in real world data and evidence, lays the groundwork for technological innovation in the pharmaceutical and clinical research sectors.

The project expands on the success of their long-standing multi-disease strategic research partnership.

The initiative will give Arcturis researchers access to the trust's extensive, anonymized oncology data housed within the Thames Valley and Surrey Secure Data Environment for healthcare research.

Kerrie Woods, director, R&D clinical informatics for the trust, said: "Arcturis has unique expertise in integrating molecular and clinical data and curating fit-for-purpose regulatory-grade research datasets.

"This valuable work will help to improve the quality and completeness of the data available for world-class research, driving real world impact."

Christie Brooks, director, data strategy and partnerships for Arcturis, added: "Arcturis and Oxford University Hospitals are pleased to build upon our longstanding successful research partnership with this exciting initiative to deliver a precision approach to cancer evidence generation.

"The partnership is committed to enabling new treatment options to be better evaluated by regulators, data-driven innovation to be more informed by UK patients’ needs and the NHS to benefit from the wealth of data that our health system generates.”